Premature birth and insulin resistance in infancy: A prospective cohort study

Vikas Payal1, Rakesh Jora1, Pramod Sharma1

  • 1Department of Pediatrics, Dr. S.N. Medical College, Umaid Hospital, Jodhpur, Rajasthan, India.

Insights

Preterm birth and small for gestational age status are significant risk factors for developing insulin resistance in infancy. These conditions can predict future metabolic health challenges early in life.

Area of Science:

  • Neonatal Research
  • Metabolic Health
  • Pediatric Endocrinology

Background:

  • Infant insulin sensitivity is crucial for long-term metabolic health.
  • Prematurity and intrauterine growth restriction are potential risk factors for later metabolic dysfunction.
  • Early identification of infants at risk for insulin resistance is essential for timely intervention.

Purpose of the Study:

  • To investigate the role of prematurity and small for gestational age (SGA) status in predicting insulin sensitivity during infancy.
  • To identify key variables that predict insulin resistance in infants.
  • To establish the early development of insulin resistance in preterm infants.

Main Methods:

  • A prospective study involving preterm appropriate for gestational age (AGA), preterm SGA, term SGA, and term AGA infants.
  • Anthropometric assessments were conducted at birth and at 3, 6, and 9 months.
  • Fasting plasma glucose and serum insulin levels were measured at 9 months to calculate insulin resistance using the homeostasis model assessment (HOMA-2).

Main Results:

  • Preterm AGA, preterm SGA, and term SGA infants exhibited significantly higher insulin resistance compared to term AGA controls.
  • Small for gestational age (SGA) status was a more significant predictor of insulin resistance than gestational age, weight-for-length, or ponderal index.
  • No significant difference in insulin resistance was observed between preterm SGA and preterm AGA infants.

Conclusions:

  • Preterm birth is identified as a significant risk factor for the future development of insulin resistance.
  • Insulin resistance can manifest as early as infancy in infants born preterm.
  • SGA status is a critical predictor of infant insulin resistance, highlighting the importance of monitoring growth and metabolic parameters.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.7K